| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |